• Confined placental mosaicism: mechanisms of origin and the prospects for prediction
en To content

Confined placental mosaicism: mechanisms of origin and the prospects for prediction

PERINATOLOGIYA I PEDIATRIYA.2014.4(60):14–17;doi10.15574/PP.2014.60.14

 

Confined placental mosaicism: mechanisms of origin and the prospects for prediction

Gordiyenko I.Yu. ,  Nikitchina T.V.,  Vashchenko O.A., Tarapurova E.N. , Velichko A.V.,  Bolyukh V.M.

 

SI «Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine», Kiev, Ukraine

 

Object — to conduct the analysis of the results of cytogenetic examinations of chorion and placenta in high_risk pregnant women.

Patients and methods. A total of 3724 high-risk pregnant women were under observation. Prenatal ultrasound examinations were performed in real time with the use of ACCUVIX V20EX-EXP, ACCUVIX V10LV-EX, Aloka SSD — 630, HDI 4000 devices. Invasive procedures were conducted under the standard, according to the testimony. For cytogenetic studies of chronic biopsy and the placenta was used the direct method of fixing [Flori E. et al., 1985; Baranov V.S. et al., 1990] in the own modification. Culturing and fixing of cord blood lymphocytes was conducted by the use of semimicromethod [Hungerford D. et al., 1965]. Preparations of chromosomes were analyzed by the use of light microscopy BX51 (Olympus) and BX53 (Olympus) extended at x10000. The analysis results are recorded on the international nomenclature (ISCN, 2013).

 

Results. Confined placental mosaicism was detected in 23 (0.62%) cases. By virtue of additional research the normal karyotype of the fetus was diagnosed in 19 (0.5%) cases, and chromosomal pathology — only in 4 (0.1%). The false negative result is obtained in 2 cases (in fetuses of different sex).

 

Conclusions. All cases of the confined placental mosaicism requires detailed further examination.

 

Key words: confined placental mosaicism, chromosomal abnormality, invasive prenatal diagnosis.

 

REFERENCES

 

 

1. Баранов ВС, Кузнецова ТВ. 2007. Цитогенетика эмбрионального развития человека. Санкт-Петербург: Изд-во Н-Л: 640.

2. Гордиенко И.Ю. 1999. Аспирация ворсин хориона и плаценты. Врожденные пороки развития: пренатальная диагностика и тактика. Под ред. Петриковского БМ, Медведева МВ, Юдиной ЕВ. 1-е изд. Москва: РАВУЗДПГ, Реальное Время: 256.

3. Лебедев ИН, Назаренко СА. 2001. Тканеспецифичный плацентарный мозаицизм по аутосомным трисомиям у спонтанных абортусов человека: механизмы формирования и фенотипические эффекты. Генетика. 37,11: 1459—1474.

4. Гордієнко ІЮ, Величко АВ, Тарапурова ОМ та ін. 2012. Новий пренатальний ультразвуковий маркер в діагностиці синдрому Дауна у плода. Здоровье женщины. 3(69): 182—187.

5. Кашеварова АА, Суханова НН, Толмачева ЕН и др. 2007. Ретроспективная молекулярно-цитогенетическая характеристика тетраплоидии при ранней эмбриолетальности у человека. Цитология. 49,4: 322—328.

6. Гордієнко ІЮ, Тарапурова ОМ, Нікітчина ТВ та ін. 2013. Ультразвукові маркери хромосомних та структурних аномалій плода в другому триместрі вагітності. Методичні рекомендації. МОЗ України, ДУ «Центральний методичний кабінет з вищої медичної освіти МОЗ України». Київ-Харків: 36.

7. Sikkema-Raddatz B, Verschuuren-Bemelmans CC, Kloosterman M, de Jong B. 1997, Nov. A 46,XX,der(13;14)(q10;q10),+21 child born after a 45,XX,der(13;14)(q10;q10) chromosomal finding in CVS. Prenat Diagn. 17(11): 1086—1088.

8. Bielanska M, Tan SL, Ao A. 2002. Chromosomal mosaicism throughout human preimplantation development in vitro: incidence, type and relevance to embryo outcome. Hum Reprod. 17,2: 413—419.

9. Griffin DK, Millie EA, Redline RW et al. 1997. Cytogenetic analysis of spontaneous abortions: Comparison of techniques and assessment of the incidence of confined placental mosaicism. Am J Med Genet. 72: 297—301.

10. Ledbetter DH, Zachary JM, Simpson JL et al. 1992, May. Cytogenetic results from the U.S. Collaborative Study on CVS. Prenat Diagn. 12(5): 317—345.

11. Kennerknecht I, Barbi G, Djalali M et al. 1998, Dec. False-negative findings in chorionic villus sampling. An experimental approach and review of the literature. Prenat Diagn. 18(12): 1276—1282.

12. Fryburg JS, Dimaio MS, Mahoney MJ. 1992, Mar. Postnatal placental confirmation of trisomy 2 and trisomy 16 detected at chorionic villus sampling: a possible association with intrauterine growth retardation and elevated maternal serum alpha- fetoprotein. Prenat Diagn. 12(3): 157—162.

13. Hahnemann JM, Vejerslev LO. 1997, Sep. Accuracy of cytogenetic findings on chorionic villus sampling (CVS)-diagnostic consequences of CVS mosaicism and non-mosaic discrepancy in centres contributing to EUCROMIC 1986—1992. Prenat Diagn. 17(9): 801—820.

14. Kalousek DK, Dill FJ. 1983. Chromosomal mosaicism confined to the placenta in human conceptions. Science. 221: 665—667.

15. Kalousek DK. 2000. Pathogenesis of chromosomal mosaicism and its effect on early human development. Am J Hum Genet. 91: 39—45.

16. Kalousek DK, Barrett IJ, Gartner AB. 1992. Spontaneous abortions and confined placental mosaicism. Human Genetics. 88: 642—646.

17. Leschot NJ, Wolf H, Weenink GH. 1988, Sep. False negative findings at third trimester chorionic villus sampling (C.V.S.). Clin Genet. 34(3): 204—205.

18. Los FJ, van Opstal D, van den Berg C. 2004. The development of cytogenetically normal, abnormal and mosaic embryos: a theoretical model. Hum Reprod Upd. 10: 79—94.

19. Pindar L, Whitehouse M, Ocraft K. 1992, Jun. A rare case of a false-negative finding in both direct and culture of a chorionic villus sample. Prenat Diagn. 12(6): 525—527.

20. Morssink LP, Sikkema-Raddatz B, Beekhuis JR et al. 1996, Sep. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels. Prenat Diagn. 16(9): 845—851.

21. Sanchez JM, Lopez De Diaz S, Panal MJ et al. 1997, Aug. Severe fetal malformations associated with trisomy 16 confined to the placenta. Prenat Diagn. 17(8): 777—779.

22. Simoni G, Sirchia SM. 1994. Confined placental mosaicism. Prenatal Diagnosis. 14: 1185—1189.

23. Morssink LP, de Wolf BT, Kornman LH et al. 1996, Aug. The relation between serum markers in the second trimester and placental pathology. A study on extremely small for gestational age fetuses. Br J Obstet Gynaecol. 103(8): 779—783.

24. Vejerslev LO, Mikkelsen M. 1989, Aug. The European collaborative study on mosaicism in chorionic villus sampling: data from 1986 to 1987. Prenat Diagn. 9(8): 575—588.

25. Wolstenholme J, Rooney DE, Davison EV. 1994, May. Confined placental mosaicism, IUGR, and adverse pregnancy outcome: a controlled retrospective U.K. collaborative survey. Prenat Diagn. 14(5): 345—361.